News & Trends - Pharmaceuticals

Legislative changes for improved access to important medicines

Health Industry Hub | June 29, 2020 |
[Total: 1    Average: 4/5]

Pharma News: Queenslanders will now have improved access to oral contraceptives and medicinal cannabis following legislative amendments made by the Queensland Government.

While women have been able to access a supply of PBS subsidised oral contraceptive without a valid repeat prescription since 2012, this amendment will provide access to non-PBS subsidised brands of oral contraceptives.

Pharmaceutical Society of Australia (PSA) Queensland Branch President Shane MacDonald welcomed the amendment that will help address the inequity of access to oral contraceptives.

“Enabling the supply of all brands of oral contraceptives to women, under similar circumstances to those stipulated in the PBS Continued Dispensing Determination is a common sense approach by the Queensland Government, he said.

“It is important that women in Queensland are able to access the brand of oral contraceptive they require when there is an immediate need for the supply to allow for continued treatment.”

The Queensland Government also announced it has made an amendment allowing all Queensland medical practitioners to prescribe schedule 8 and schedule 4 medicinal cannabis without the requirement to have a Queensland Health approval.

Previously, only specialist medical practitioners were able to prescribe these medicines without first applying for Queensland Health approval.

Mr MacDonald said this amendment will remove duplication in the approval process and simplify prescribing of medicinal cannabis.

“Decreasing the administrative burden and improving access to medicinal cannabis is an important step to ensure patients continue to access cannabis products legally,” he said.

“Any process that removes red tape and allows pharmacists and prescribers to focus on clinical care and medication safety, ultimately leads to better outcomes for patients and more efficient use of resource.

Approval from Queensland Health is still required when prescribing a schedule 8 medicinal cannabis product for a drug dependent person and the usual approval process for prescribing controlled drugs applies.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]

More


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]

More


Medical

Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]

More